Skip to main content

PGT-M conditions

This table shows all PGT-M conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgtm@hfea.gov.uk.

Condition name Status OMIM number Documents
Convulsions, Familial Infantile, with Paroxysmal Choreoathetosis, approved 602066
Cowden syndrome (CS)/PTEN Hamartoma Tumour Syndrome (PHTS) approved 601728, 158350, 153480, 605309
Craniofrontonasal syndrome (CFNS) approved 304110
Crigler-Najjar Syndrome Type 1 (CN1) approved 218800
Crouzon Syndrome approved 123500
Crouzon with acanthosis nigrans syndrome approved 612247
Currarino Syndrome approved 176450
Cutis Laxa, autosomal dominant 1 (ADCL1) approved 123700
Cutis Laxa, autosomal recessive, type IA (ARCL1A) approved 219100
Cutis Laxa, autosomal recessive, type IB (ARCL1B) approved 614437
Cutis Laxa, autosomal recessive, type IC (ARCL1C) approved 613177
Cutis Laxa, autosomal recessive, type IIA (ARCL2A) approved 219200
Cutis Laxa, autosomal recessive, type IIB; ARCL2B approved 612940
Cutis Laxa, autosomal recessive, type IIC (ARCL2C), approved 617402
Cutis Laxa, autosomal recessive, type IID (ARCL2D) approved 617403
Cutis Laxa, autosomal recessive, type IIIA (ARCL3A) approved 219150
Cutis Laxa, autosomal recessive, type IIIB (ARCL3B) approved 614438
Cystic Fibrosis (CF) approved 219700
Czech Dysplasia, metatarsal type also known as Progressive pseudorheumatoid dysplasia with hypoplastic toes approved 609162
Danon Disease approved 300257